Newsletter

Menu

Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan

By Staff Correspondent |

Bristol-Myers-Squibb (NASDAQ: BMY) announced that Amgen (NASDAQ: AMGN) will acquire Celgene’s (NASDAQ: CELG) Otezla business for $13.4 billion in a cash transaction. Bristol-Myers now expects to complete the pending merger with Celgene by the end of 2019. During the pre-market trading session, both BMY and CELG increased about 4% and AMGN stock dropped about 1%.

Bristol-Myers Squibb (BMY) announces agreement between Celgene (CELG) and Amgen (AMGN) to divest OTEZLA for $13.4 billion

Under the terms of the agreement and subject to the closing conditions, Amgen will acquire OTEZLA and related intellectual property, including any patents that primarily cover apremilast, as well as other assets and liabilities related to OTEZLA. The agreement includes the transfer of Celgene employees primarily dedicated to OTEZLA.

“This agreement represents an important step toward completing our pending merger with Celgene. It also demonstrates the tremendous achievement of the Celgene team in establishing OTEZLA as an important medicine for patients with psoriasis, psoriatic arthritis and Behçet’s Disease,” said Bristol-Myers CEO Giovanni Caforio.

Also read: Bristol-Myers Q2 earnings, revenue top Street; stock dips on weak guidance

Shareholders of Celgene and Bristol-Myers approved the merger in April. In light of the concerns expressed by the U.S. Federal Trade Commission (FTC), Bristol-Myers announced its plan to divest OTEZLA business in June. The next month, European Commission approved the merger.

When Celgene reported its Q2 results, the company projected OTEZLA sales to be about $1.9 billion in 2019. Sales of OTEZLA surged 31% to $493 million in the second quarter ended June 30, 2019.

Amgen expects the addition of OTEZLA to positively impact its financial results, including an immediate accretion to its non-GAAP EPS. Bristol-Myers plans to prioritize the use of proceeds from the OTEZLA divestiture for its debt reduction.

Amgen (AMGN) Q2 2019 earnings

Bristol-Myers Squibb also announced that it is increasing its previously planned $5 billion accelerated share repurchase to $7 billion. The share repurchase will be executed following closing of the pending Bristol-Myers Squibb merger with Celgene, subject to Board approval.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Advertisement

More on this Company

Johnson & Johnson heads into Q4 as a more focused healthcare leader

January 12, 2026
ipo news

Everything you need to know about Aktis Oncology’s upcoming IPO

December 26, 2025
Micron Q1 2026 Earnings

Micron Q1 2026 earnings beat estimates; revenue surges 57%

December 17, 2025

67 responses to “Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan”

  4. webcam sex

    […]check below, are some absolutely unrelated web sites to ours, however, they’re most trustworthy sources that we use[…]

  5. live sex chat

    […]Wonderful story, reckoned we could combine a number of unrelated information, nonetheless genuinely worth taking a search, whoa did one particular study about Mid East has got a lot more problerms also […]

  8. texas heeler

    […]we prefer to honor lots of other internet web-sites around the web, even though they aren’t linked to us, by linking to them. Beneath are some webpages really worth checking out[…]

  10. french bulldog for sale

    […]Wonderful story, reckoned we could combine several unrelated data, nevertheless really really worth taking a search, whoa did one particular understand about Mid East has got extra problerms as well […]

  17. Omron

    […]although internet sites we backlink to beneath are considerably not associated to ours, we feel they’re essentially really worth a go through, so possess a look[…]

  20. free adult webcams

    […]although web-sites we backlink to beneath are considerably not associated to ours, we really feel they’re basically really worth a go via, so possess a look[…]

  21. isla mujeres luxury rentals

    […]Wonderful story, reckoned we could combine several unrelated data, nonetheless genuinely worth taking a appear, whoa did one particular master about Mid East has got a lot more problerms also […]

  32. linh hoang

    […]Every the moment inside a although we opt for blogs that we read. Listed below are the newest web pages that we choose […]

  43. crypto news

    […]that will be the finish of this post. Right here you’ll uncover some web sites that we consider you will enjoy, just click the links over[…]

  47. minnect expert

    […]we like to honor numerous other internet sites around the net, even though they aren’t linked to us, by linking to them. Under are some webpages really worth checking out[…]

  60. dog registration

    […]Every as soon as inside a while we opt for blogs that we study. Listed beneath are the latest web sites that we pick out […]

  63. French Bulldog Adoption

    […]that is the finish of this write-up. Right here you’ll find some web pages that we think you’ll appreciate, just click the hyperlinks over[…]

  66. magnolia bjj

    […]that will be the finish of this post. Right here you will find some web sites that we feel you will enjoy, just click the hyperlinks over[…]

Top